Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 106 participants.

Also called NCT07920055

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 106 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07920055
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07920055. Randomized; no masking; primary purpose treatment. Start 2026-11-01 (anticipated); primary completion 2028-08-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)
Acronym
SPRIT
Condition
Coronary In-stent Restenosis
Intervention (Device)
SeQuent SCB sirolimus-coated balloon
Intervention (Drug)
RESTORE DEB paclitaxel-coated balloon
Lead sponsor
Sir Run Run Shaw Hospital (class: other)

Record details

Record id
cardio:ct-nct07920055
Content hash
a6569ef90ce180e487f8fc2072c45eeed33266a15c2d67377db51d8edbdc43f0